CXCR4 and prostate carcinoma: Interestingly, high levels of CXCR4 have been also observed in CD44+/CD133+ prostate cancer stem cells (CSC) and are associated with more frequent local recurrence and metastasis formation, suggesting a role of this receptor as a prognostic marker [23,24].